{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:52:07Z","timestamp":1791323527879,"version":"4.3.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.toxrep.2025.102179","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:22:41Z","timestamp":1765210961000},"page":"102179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Can in silico models predict drug-induced cardiac risk in vulnerable populations?"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6357-1355","authenticated-orcid":false,"given":"Paula","family":"Dominguez-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Gonzalez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baldo-Canut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Casoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ani","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Butakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Aguado-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.toxrep.2025.102179_b1","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/CIRCULATIONAHA.104.494476","article-title":"Molecular basis of arrhythmias","volume":"112","author":"Shah","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b3","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1038\/s41598-021-89478-9","article-title":"A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues","volume":"11","author":"Kofron","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2025.102179_b4","series-title":"Guidance for Industry: E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"U.S. Food and Drug Administration","year":"2005"},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b5","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/bcp.15242","article-title":"Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response","volume":"88","author":"Gross","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b6","first-page":"1","article-title":"Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study","volume":"9","author":"Gomez","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxrep.2025.102179_b7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.toxrep.2025.102179_b8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cpt.1184","article-title":"Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative","volume":"105","author":"Li","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2025.102179_b9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphys.2017.00668","article-title":"Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity","volume":"8","author":"Passini","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/15376516.2016.1256460","article-title":"Early assessment of proarrhythmic risk of drugs using the in vitro data and single-cell-based in silico models: proof of concept","volume":"27","author":"Abbasi","year":"2017","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.toxrep.2025.102179_b11","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1111\/bph.14786","article-title":"Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias","volume":"176","author":"Passini","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acs.jcim.7b00440","article-title":"In silico QT and APD prolongation assay for early screening of drug-induced proarrhythmic risk","volume":"58","author":"Romero","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.toxrep.2025.102179_b13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1476-5381.2012.02200.x","article-title":"Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials","volume":"168","author":"Zemzemi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fphys.2019.01139","article-title":"Three-dimensional heart model-based screening of proarrhythmic potential by in silico simulation of action potential and electrocardiograms","volume":"10","author":"Hwang","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b15","article-title":"Predicting drug-induced arrhythmias by multiscale modeling","volume":"34","author":"Costabal","year":"2018","journal-title":"Int. J. Numer. Methods Biomed. Eng."},{"key":"10.1016\/j.toxrep.2025.102179_b16","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1111\/bph.14357","article-title":"Arrhythmic hazard map for a 3D whole-ventricle model under multiple ion channel block","volume":"175","author":"Okada","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b17","first-page":"v90","article-title":"Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms","volume":"14","author":"Wilhelms","year":"2012","journal-title":"EP Eur."},{"key":"10.1016\/j.toxrep.2025.102179_b18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s13239-018-0347-0","article-title":"Efficient computational modeling of human ventricular activation and its electrocardiographic representation: a sensitivity study","volume":"9","author":"Cranford","year":"2018","journal-title":"Cardiovasc. Eng. Technol."},{"key":"10.1016\/j.toxrep.2025.102179_b19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fphys.2021.708435","article-title":"Sex differences in drug-induced arrhythmogenesis","volume":"12","author":"Peirlinck","year":"2021","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b20","first-page":"822","article-title":"Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction","volume":"21","author":"Le\u00f3n","year":"2019","journal-title":"EP Eur."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b21","doi-asserted-by":"crossref","first-page":"H1588","DOI":"10.1152\/ajpheart.00362.2010","article-title":"Ionic mechanisms of electrophysiological heterogeneity and conduction block in the infarct border zone","volume":"299","author":"Decker","year":"2010","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11437","article-title":"Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models","author":"Arevalo","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxrep.2025.102179_b23","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00580","article-title":"Personalized cardiac computational models: From clinical data to simulation of infarct-related ventricular tachycardia","author":"L\u00f3pez-P\u00e9rez","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b24","doi-asserted-by":"crossref","DOI":"10.1007\/s00399-017-0539-6","article-title":"Cardiac ischemia-insights from computational models","author":"Loewe","year":"2018","journal-title":"Herzschrittmachertherapie Elektrophysiologie"},{"key":"10.1016\/j.toxrep.2025.102179_b25","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104674","article-title":"Electromechanical modeling of human ventricles with ischemic cardiomyopathy: numerical simulations in sinus rhythm and under arrhythmia","author":"Salvador","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.toxrep.2025.102179_b26","series-title":"2022 Computing in Cardiology","article-title":"Using computational modelling to define the ideal characteristics of protective drugs in acute ischemia","author":"Loidi","year":"2022"},{"key":"10.1016\/j.toxrep.2025.102179_b27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53221-2","article-title":"High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence","author":"Martinez-Navarro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2025.102179_b28","article-title":"Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischaemia and its modulation by sodium current availability","author":"Martinez-Navarro","year":"2020","journal-title":"Interface Focus."},{"key":"10.1016\/j.toxrep.2025.102179_b29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbiomolbio.2017.02.007","article-title":"Electrophysiological properties of computational human ventricular cell action potential models under acute ischemic conditions","author":"Dutta","year":"2017","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102179_b30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187739","article-title":"Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure","volume":"12","author":"Mora","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxrep.2025.102179_b31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s12265-021-10130-y","article-title":"Computational modeling studies of the roles of left ventricular geometry, afterload, and muscle contractility on myocardial strains in heart failure with preserved ejection fraction","volume":"14","author":"Shavik","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"suppl_3","key":"10.1016\/j.toxrep.2025.102179_b32","first-page":"iii102","article-title":"Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. purkinje-myocardial coupling abnormalities","volume":"20","author":"Lyon","year":"2018","journal-title":"EP Eur."},{"key":"10.1016\/j.toxrep.2025.102179_b33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2015.09.003","article-title":"Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy","author":"Passini","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.toxrep.2025.102179_b34","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2014.06.013","article-title":"An in silico case study of idiopathic dilated cardiomyopathy via a multi-scale model of the cardiovascular system","author":"Bhattacharya-Ghosh","year":"2014","journal-title":"Comput. Biol. Med."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102179_b35","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/bph.15757","article-title":"Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation","volume":"179","author":"TeBay","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1370795","article-title":"Fibrosis modeling choice affects morphology of ventricular arrhythmia in non-ischemic cardiomyopathy","author":"Myklebust","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1379236","article-title":"Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy","author":"Coleman","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2023.107860","article-title":"Combining pharmacokinetic and electrophysiological models for early prediction of drug-induced arrhythmogenicity","author":"Llopis-Lorente","year":"2023","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.toxrep.2025.102179_b39","series-title":"Heart database","author":"University of Minnesota Visible Heart Laboratories","year":"2025"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jelectrocard.2006.09.003","article-title":"Electrocardiographic reference ranges derived from 79,743 ambulatory subjects","volume":"40","author":"Mason","year":"2007","journal-title":"J. Electrocardiol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263639","article-title":"Ventricular anatomical complexity and sex differences impact predictions from electrophysiological computational models","volume":"18","author":"Gonzalez-Martin","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.toxrep.2025.102179_b42","series-title":"Intraoperative Imaging and Image-Guided Therapy","first-page":"277","article-title":"3D Slicer: a platform for subject-specific image analysis, visualization, and clinical support","author":"Kikinis","year":"2013"},{"key":"10.1016\/j.toxrep.2025.102179_b43","doi-asserted-by":"crossref","DOI":"10.54294\/efycla","article-title":"Histogram-based thresholding - some missing methods","author":"Beare","year":"2011","journal-title":"Insight J."},{"key":"10.1016\/j.toxrep.2025.102179_b44","series-title":"Seg3D: Volumetric image segmentation and visualization. Scientific computing and imaging institute","author":"University of Utah","year":"2025"},{"key":"10.1016\/j.toxrep.2025.102179_b45","series-title":"ACM SIGGRAPH 2010 Talks","article-title":"Meshmixer: an interface for rapid mesh composition","author":"Schmidt","year":"2010"},{"key":"10.1016\/j.toxrep.2025.102179_b46","series-title":"ANSA: The advanced CAE pre-processing software for complete model build up","author":"BETA CAE Systems","year":"2025"},{"key":"10.1016\/j.toxrep.2025.102179_b47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jocs.2015.12.007","article-title":"Alya: Multiphysics engineering simulation toward exascale","volume":"14","author":"V\u00e1zquez","year":"2016","journal-title":"J. Comput. Sci."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102179_b48","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cnm.1443","article-title":"A massively parallel computational electrophysiology model of the heart","volume":"27","author":"V\u00e1zquez","year":"2011","journal-title":"Int. J. Numer. Methods Biomed. Eng."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b49","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O\u2019Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.toxrep.2025.102179_b50","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","volume":"8","author":"Dutta","year":"2017","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt.2240","article-title":"Sex-specific classification of drug-induced torsade de pointes susceptibility using cardiac simulations and machine learning","volume":"110","author":"Iseppe","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2025.102179_b52","doi-asserted-by":"crossref","first-page":"33341","DOI":"10.3389\/fphys.2012.00360","article-title":"In silico prediction of sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias","volume":"3","author":"Yang","year":"2012","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b53","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.41.6.899","article-title":"Total excitation of the isolated human heart","volume":"41","author":"Durrer","year":"1970","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b54","doi-asserted-by":"crossref","DOI":"10.1002\/cnm.3185","article-title":"A rule-based method to model myocardial fiber orientation in cardiac biventricular geometries with outflow tracts","volume":"35","author":"Doste","year":"2019","journal-title":"Int. J. Numer. Methods Biomed. Eng."},{"key":"10.1016\/j.toxrep.2025.102179_b55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.RES.0000016960.61087.86","article-title":"Ionic current basis of electrocardiographic waveforms: a model study","volume":"90","author":"Gima","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxrep.2025.102179_b56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jtbi.2008.03.029","article-title":"Minimal model for human ventricular action potentials in tissue","volume":"253","author":"Bueno-Orovio","year":"2008","journal-title":"J. Theoret. Biol."},{"key":"10.1016\/j.toxrep.2025.102179_b57","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1016\/j.bpj.2011.09.060","article-title":"A multiscale investigation of repolarization variability and its role in cardiac arrhythmogenesis","volume":"101","author":"Pueyo","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.toxrep.2025.102179_b58","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1109\/TBME.2020.3043844","article-title":"Characterization of T wave amplitude, duration, and morphology changes during hemodialysis: relationship with serum electrolyte levels and heart rate","volume":"68","author":"Bukhari","year":"2021","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.toxrep.2025.102179_b59","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1060919","article-title":"Differences in ventricular wall composition may explain inter-patient variability in the ECG response to variations in serum potassium and calcium","volume":"14","author":"Bukhari","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b60","first-page":"3","article-title":"M-cells are present in the ventricular myocardium","volume":"8","author":"Wilson","year":"2011","journal-title":"Hear. Rhythm. : Off. J. Hear. Rhythm. Soc."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.72.3.671","article-title":"Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle","volume":"72","author":"Liu","year":"1993","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b62","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.109.204891","article-title":"Transmural dispersion of repolarization in failing and nonfailing human ventricle","volume":"106","author":"Glukhov","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxrep.2025.102179_b63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-0736(99)90074-2","article-title":"Transmural dispersion of repolarization and arrhythmogenicity: The brugada syndrome versus the long QT syndrome","volume":"32","author":"Antzelevitch","year":"1999","journal-title":"J. Electrocardiol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbiomolbio.2015.12.002","article-title":"Variability in cardiac electrophysiology: Using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm","volume":"120","author":"Muszkiewicz","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.toxrep.2025.102179_b65","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2024.107498","article-title":"Virtual clinical QT exposure-response studies \u2013 A translational computational approach","volume":"126","author":"Aguado-Sierra","year":"2024","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.toxrep.2025.102179_b66","series-title":"High Performance Computing for Drug Discovery and Biomedicine","first-page":"307","article-title":"HPC framework for performing in silico trials using a 3D virtual human cardiac population as means to assess drug-induced arrhythmic risk","author":"Aguado-Sierra","year":"2024"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0056359","article-title":"mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling: A population-based simulation study","volume":"8","author":"Walmsley","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b68","doi-asserted-by":"crossref","first-page":"H1436","DOI":"10.1152\/ajpheart.00263.2009","article-title":"Impact of ionic current variability on human ventricular cellular electrophysiology","volume":"297","author":"Romero","year":"2009","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.toxrep.2025.102179_b69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pbiomolbio.2007.07.011","article-title":"Contributions of HERG K+ current to repolarization of the human ventricular action potential","volume":"96","author":"Fink","year":"2008","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.toxrep.2025.102179_b70","first-page":"H98","article-title":"Transmembrane I(Ca) contributes to rate-dependent changes of action potentials in human ventricular myocytes","volume":"276","author":"Li","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.toxrep.2025.102179_b71","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cardiores.2004.11.022","article-title":"Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium","volume":"65","author":"Szentandrassy","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b72","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1536\/ihj.46.1105","article-title":"Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes","volume":"46","author":"Verkerk","year":"2005","journal-title":"Int. Hear. J."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b73","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0008-6363(00)00306-0","article-title":"The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes","volume":"49","author":"Vir\u00e1g","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054635","article-title":"Gender differences in electrophysiological gene expression in failing and nonfailing human hearts","volume":"8","author":"Ambrosi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxrep.2025.102179_b75","doi-asserted-by":"crossref","first-page":"M40","DOI":"10.1093\/eurheartj\/suz212","article-title":"Heart failure in dilated non-ischaemic cardiomyopathy","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur. Hear. J. Suppl."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"issue":"1954","key":"10.1016\/j.toxrep.2025.102179_b77","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1098\/rsta.2011.0139","article-title":"Verification of cardiac tissue electrophysiology simulators using an N-version benchmark","volume":"369","author":"Niederer","year":"2011","journal-title":"Philos. Trans. R. Soc. A: Math. Phys. Eng. Sci."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.RES.0000059301.81035.06","article-title":"Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts","volume":"92","author":"Yao","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.toxrep.2025.102179_b79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.toxrep.2025.102179_b80","first-page":"1","article-title":"Scientific white paper on concentration-QTc modeling","volume":"45","author":"Garnett","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.toxrep.2025.102179_b81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.hrthm.2009.02.044","article-title":"The QT interval: Too long, too short or just right","volume":"6","author":"Viskin","year":"2009","journal-title":"Hear. Rhythm. : Off. J. Hear. Rhythm. Soc."},{"key":"10.1016\/j.toxrep.2025.102179_b82","series-title":"Moxifloxacin (systemic) monograph","author":"Drugs.com","year":"2024"},{"key":"10.1016\/j.toxrep.2025.102179_b83","series-title":"Quinidine monograph","author":"Drugs.com","year":"2024"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b84","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.3746","article-title":"Use of quinine and mortality-risk in patients with heart failure\u2014a Danish nationwide observational study","volume":"24","author":"Gjesing","year":"2015","journal-title":"Pharmacoepidemiol. Drug Safety"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.30.1.17","article-title":"Quinidine syncope","volume":"30","author":"Selzer","year":"1964","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b86","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.CIR.64.6.1167","article-title":"Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients","volume":"64","author":"Keren","year":"1981","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(79)90326-6","article-title":"Polymorphous ventricular tachycardia: clinical features and treatment","volume":"44","author":"Sclarovksy","year":"1979","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.toxrep.2025.102179_b88","series-title":"Bepridil drug information","author":"RxList.com","year":"2022"},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b89","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1253\/circj.70.662","article-title":"Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter","volume":"70","author":"Yasuda","year":"2006","journal-title":"Circ. J."},{"key":"10.1016\/j.toxrep.2025.102179_b90","series-title":"Flecainide monograph","author":"Drugs.com","year":"2024"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5603\/CJ.a2023.0018","article-title":"Flecainide in clinical practice","volume":"30","author":"Basza","year":"2023","journal-title":"Cardiol. J."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b92","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-106-6-807","article-title":"Life-threatening flecainide toxicity","volume":"106","author":"Winkelmann","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.toxrep.2025.102179_b93","series-title":"Quantitative Human Physiology","first-page":"528","article-title":"5.5 - The cardiac action potential","author":"Feher","year":"2012"},{"issue":"12","key":"10.1016\/j.toxrep.2025.102179_b94","doi-asserted-by":"crossref","first-page":"H1426","DOI":"10.1152\/ajpheart.00457.2012","article-title":"Right ventricular arrhythmogenesis in failing human heart: the role of conduction and repolarization remodeling","volume":"303","author":"Lou","year":"2012","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b95","article-title":"Repolarization reserve and action potential dynamics in failing myocytes","volume":"11","author":"Fu","year":"2018","journal-title":"Circ.: Arrhythmia Electrophysiol."},{"issue":"10","key":"10.1016\/j.toxrep.2025.102179_b96","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102767","article-title":"Electrical ventricular remodeling in dilated cardiomyopathy","volume":"10","author":"Mages","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b97","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1152\/physrev.1999.79.3.917","article-title":"Cardiac ionic currents and acute ischemia: From channels to arrhythmias","volume":"79","author":"Carmeliet","year":"1999","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102179_b98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126467","article-title":"Dynamic changes in ion channels during myocardial infarction and therapeutic challenges","volume":"25","author":"Song","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.102179_b99","first-page":"1","article-title":"QT interval and short-term outcome in acute heart failure","author":"Mir\u00f3","year":"2023","journal-title":"Clin. Res. Cardiol."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102179_b100","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2005.01.071","article-title":"Significance of QRS complex duration in patients with heart failure","volume":"46","author":"Kashani","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.toxrep.2025.102179_b101","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ejhf.1815","article-title":"The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy","volume":"22","author":"Finocchiaro","year":"2020","journal-title":"Eur. J. Hear. Fail."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1542-474X.2005.05583.x","article-title":"Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects","volume":"10","author":"Alonso","year":"2005","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b103","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.96.5.1557","article-title":"Beat-to-beat QT interval variability","volume":"96","author":"Berger","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.toxrep.2025.102179_b104","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1178163","article-title":"The pivotal role of ECG in Cardiomyopathies","volume":"10","author":"Silvetti","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.toxrep.2025.102179_b105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehr021","article-title":"Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy","volume":"32","author":"Johnson","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.toxrep.2025.102179_b106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelectrocard.2013.04.005","article-title":"ST-elevation and non-ST-elevation acute coronary syndromes: Should the guidelines be changed?","volume":"46","author":"Gorgels","year":"2013","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.toxrep.2025.102179_b107","series-title":"ECG in 10 Days, 2e","article-title":"Ischemia and infarction","author":"Ferry","year":"2007"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102179_b108","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/hrt.73.1.32","article-title":"QT dispersion and components of the QT interval in ischaemia and infarction","volume":"73","author":"Higham","year":"1995","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102179_b109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/bcp.12201","article-title":"Are women more susceptible than men to drug-induced QT prolongation? concentration\u2013QTc modelling in a phase 1 study with oral rac-sotalol","volume":"77","author":"Darpo","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102179_b110","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1112759","article-title":"Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease?","volume":"10","author":"Cava","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b111","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/joa3.12215","article-title":"Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization","volume":"35","author":"Tripathi","year":"2019","journal-title":"J. Arrhythmia"},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b112","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","article-title":"Measurement, interpretation and clinical potential of QT dispersion","volume":"36","author":"Malik","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b113","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jelectrocard.2006.10.006","article-title":"Short- and long-term prognostic value of the corrected QT interval in the non\u2013ST-elevation acute coronary syndrome","volume":"40","author":"Jim\u00e9nez-Candil","year":"2007","journal-title":"J. Electrocardiol."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102179_b114","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.CIR.57.6.1074","article-title":"QT interval prolongation as predictor of sudden death in patients with myocardial infarction","volume":"57","author":"Schwartz","year":"1978","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.toxrep.2025.102179_b115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cpt.60","article-title":"Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase","volume":"97","author":"Darpo","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.toxrep.2025.102179_b116","article-title":"Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap","volume":"13","author":"Reza","year":"2022","journal-title":"Am. Hear. J. Plus: Cardiol. Res. Pr."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102179_b117","first-page":"135","article-title":"Representation of women in randomized clinical trials of cardiovascular disease prevention","volume":"3","author":"Melloni","year":"2010","journal-title":"Circ.: Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.toxrep.2025.102179_b118","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11897-021-00526-x","article-title":"Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment","volume":"18","author":"Butters","year":"2021","journal-title":"Curr. Hear. Fail. Rep."},{"key":"10.1016\/j.toxrep.2025.102179_b119","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00133207","article-title":"Myocardial infarction: Is bepridil, a new calcium antagonist, able to improve the course of the acute phase?","volume":"2","author":"Flammang","year":"1989","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102179_b120","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00005344-198609000-00012","article-title":"Electrophysiologic effects of bepridil in normal and infarcted canine myocardium","volume":"8","author":"Lynch","year":"1986","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"22","key":"10.1016\/j.toxrep.2025.102179_b121","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.toxrep.2025.102179_b122","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48890","article-title":"Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block","volume":"8","author":"Tomek","year":"2019","journal-title":"ELife"},{"issue":"10","key":"10.1016\/j.toxrep.2025.102179_b123","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/cvr\/cvaa280","article-title":"Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events","volume":"117","author":"Ballouz","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"23","key":"10.1016\/j.toxrep.2025.102179_b124","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."}],"updated-by":[{"DOI":"10.1016\/j.toxrep.2026.102351","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000}}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:15:37Z","timestamp":1786533337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":124,"alternative-id":["S2214750025002987"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102179","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.09.22.677793","asserted-by":"object"}]},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can in silico models predict drug-induced cardiac risk in vulnerable populations?","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102179"}}